These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8228483)

  • 21. [Evaluation of clinical efficacy of platelet substitution in acute leukemia using resonance thrombography].
    Anders O; Ernst B; Hess G; Konrad H; Lakner V; Seyfarth M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(4):587-93. PubMed ID: 2414188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transfusion-refractory thrombocytopenia during chemotherapy: pathogenesis, frequency and treatment].
    Helleberg C; Taaning EB; Johnsen HE
    Ugeskr Laeger; 1995 Sep; 157(37):5082-6. PubMed ID: 7502374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of HLA alloimmunization and other factors on the effectiveness of thrombocyte concentrates].
    Pittrová H; Koza V; Cepelák V; Bufková D
    Cas Lek Cesk; 1990 Jun; 129(24):751-3. PubMed ID: 2393882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clot: platelet transfusion.
    Chapman R
    Rocky Mt Med J; 1977; 74(3):146-50. PubMed ID: 301288
    [No Abstract]   [Full Text] [Related]  

  • 25. The mechanism of platelet aggregation induced by HLA-related antibodies.
    Brandt JT; Julius CJ; Osborne JM; Anderson CL
    Thromb Haemost; 1996 Nov; 76(5):774-9. PubMed ID: 8950789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet replacement therapy: a clinical assessment.
    Hester JP; McCredie KB; Freireich EJ
    Prog Clin Biol Res; 1978; 28():281-93. PubMed ID: 752154
    [No Abstract]   [Full Text] [Related]  

  • 27. Transfusion-associated graft-versus-host disease.
    Anderson KC; Weinstein HJ
    N Engl J Med; 1990 Aug; 323(5):315-21. PubMed ID: 2248640
    [No Abstract]   [Full Text] [Related]  

  • 28. Graft vs host disease following kidney transplantation using an '0 HLA antigen mismatched' donor.
    Smith DM; Agura ED; Levy MF; Melton LB; Domiati-Saad R; Klintmalm G
    Nephrol Dial Transplant; 2006 Sep; 21(9):2656-9. PubMed ID: 16627604
    [No Abstract]   [Full Text] [Related]  

  • 29. Brief report: graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors.
    Shivdasani RA; Haluska FG; Dock NL; Dover JS; Kineke EJ; Anderson KC
    N Engl J Med; 1993 Mar; 328(11):766-70. PubMed ID: 8437597
    [No Abstract]   [Full Text] [Related]  

  • 30. The immunogenicity of white cell fragments in platelet concentrates.
    Navarrete C; Contreras M
    Vox Sang; 2006 Apr; 90(3):205; author reply 206. PubMed ID: 16507023
    [No Abstract]   [Full Text] [Related]  

  • 31. Variable expression of w4 and w6 on platelets: possible relevance to platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duquesnoy RJ; Testin J; Aster RH
    Transplant Proc; 1977 Dec; 9(4):1829-31. PubMed ID: 601844
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery.
    Thaler M; Shamiss A; Orgad S; Huszar M; Nussinovitch N; Meisel S; Gazit E; Lavee J; Smolinsky A
    N Engl J Med; 1989 Jul; 321(1):25-8. PubMed ID: 2786605
    [No Abstract]   [Full Text] [Related]  

  • 33. Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duqesnoy RJ
    Prog Clin Biol Res; 1978; 28():229-43. PubMed ID: 88057
    [No Abstract]   [Full Text] [Related]  

  • 34. Sphingosine-phosphate content in the plasma of platelet concentrates correlates with poor platelet increments after transfusion and with occurrences of transfusion reactions in patients.
    Igarashi Y; Yatomi Y; Kickler TS
    Am J Hematol; 1998 Mar; 57(3):261-2. PubMed ID: 9495385
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
    Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indications for platelet transfusion in patients with thrombocytopenia.
    Squires JE
    Blood Transfus; 2015 Apr; 13(2):221-6. PubMed ID: 25369586
    [No Abstract]   [Full Text] [Related]  

  • 38. Graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets.
    Takanashi M; Nishimura M; Tadokoro K; Juji T
    Transfusion; 1995 Mar; 35(3):276-7. PubMed ID: 7878725
    [No Abstract]   [Full Text] [Related]  

  • 39. [Application of platelet transfusion and their problems].
    Ryo R; Hashimoto M; Takada S; Goto M; Yamaguchi N
    Nihon Naika Gakkai Zasshi; 1993 Jul; 82(7):1047-52. PubMed ID: 8228483
    [No Abstract]   [Full Text] [Related]  

  • 40. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.